File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study

TitleNivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study
Authors
Yau, TCCHsu, CKim, TYChoo, SKang, YKHou, MMNumata, KYeo, WChopra, AIkeda, MKuromatsu, RMoriguchi, M
KeywordsHCC
Hepatocellular carcinoma
Liver cancer
Nivolumab
PD-1 inhibitor
Issue Date2019
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
Journal of Hepatology, 2019, v. 71 n. 3, p. 543-552 How to Cite?
DOI: http://dx.doi.org/10.1016/j.jhep.2019.05.014
Persistent Identifierhttp://hdl.handle.net/10722/266016
ISSN
0168-8278
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112
ISI Accession Number ID
WOS:000496939900041

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.contributor.authorHsu, C-
dc.contributor.authorKim, TY-
dc.contributor.authorChoo, S-
dc.contributor.authorKang, YK-
dc.contributor.authorHou, MM-
dc.contributor.authorNumata, K-
dc.contributor.authorYeo, W-
dc.contributor.authorChopra, A-
dc.contributor.authorIkeda, M-
dc.contributor.authorKuromatsu, R-
dc.contributor.authorMoriguchi, M-
dc.date.accessioned2018-12-17T02:16:33Z-
dc.date.available2018-12-17T02:16:33Z-
dc.date.issued2019-
dc.identifier.citationJournal of Hepatology, 2019, v. 71 n. 3, p. 543-552-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/266016-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectHCC-
dc.subjectHepatocellular carcinoma-
dc.subjectLiver cancer-
dc.subjectNivolumab-
dc.subjectPD-1 inhibitor-
dc.titleNivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.jhep.2019.05.014-
dc.identifier.pmid31668671-
dc.identifier.scopuseid_2-s2.0-85068818799-
dc.identifier.hkuros296382-
dc.identifier.volume71-
dc.identifier.issue3-
dc.identifier.spage543-
dc.identifier.epage552-
dc.identifier.isiWOS:000496939900041-
dc.publisher.placeNetherlands-
dc.identifier.issnl0168-8278-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats